Autopsy and Photon Counting Computed Tomography to Evaluate Thromboses Related to Central Venous Catheters
PHOTO CAT
1 other identifier
observational
75
1 country
1
Brief Summary
Central venous (CVC) is essential in modern healthcare but unfortunately associated with complications, including thrombosis. In a recently published study, it was showed that 12 out of 12 deceased patients had subclinical CVK-related thrombosis (Rockholt et al.). To shed light on this problem, the current studies were designed. In sub-study 1, deceased patients with CVC who are referred for clinical autopsy are included. Before the autopsy, the deceased will be examined with a photon-counting computed tomography (CT) scan and the results will be compared. In sub-study 2, living patients with CVC who are referred for various CT scans without contrast, are included. After informed consent, the patient will be examined with the photon-counting CT, whose reliability has been validated in Part 1 and the incidence of subclinical CVC-related thrombosis will be reported.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 11, 2024
CompletedFirst Posted
Study publicly available on registry
May 16, 2024
CompletedStudy Start
First participant enrolled
January 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
April 28, 2026
April 1, 2026
2.4 years
May 11, 2024
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
The incidence of venous thrombosis related to a central venous catheter in diseased patients
Venous thrombosis related to a central venous catheter detected at autopsy
At autopsy
The performance of the photon counting CT on diseased patients
The performance of the photon counting CT will be evaluated by comparing the findings from the CT with the findings from the autopsy
After death. The CT scan and the autopsy will be performed within 1 week after death
The incidence of venous thrombosis related to a central venous catheter in living patients
The incidence of venous thrombosis related to a central venous catheter in living patients detected with a photon counting CT
At CT scan
The performance of ultrasound compared to the photon counting CT
The performance of ultrasound compared to the photon counting CT in detecting enous thrombosis related to central venous catheters
Ultrasound will be performed ±24 hours from the CT
Study Arms (2)
Diseased patients with an indwelling central venous catheter
Sub study 1, Diseased patients with an indwelling central venous catheter
Living patients with an indwelling central venous catheter
Living patients with an indwelling central venous catheter who are referred to a CT-scan without intravenous contrast
Interventions
Patients will be investigated using a photon counting CT. Prior to the investigation patients will be investigated with ultrasound. The results from the two modalities will be compared
Photon counting CT is performed and the results are compared to the results of the autopsy
Eligibility Criteria
Substudy 1: Diseased patients with an indwelling central venous catheter and a clinical indication for autopsy Substudy 2: Living patients with an indwelling central venous catheter who are referred to a CT scan without iv contrast
You may qualify if:
- Diseased patients with an indwelling central venous catheter and a clinical indication for autopsy
- Informed and signed consent from next of kind
You may not qualify if:
- None
- Living patients with an indwelling central venous catheter who are referred to a CT scan without iv contrast
- Informed and signed consent from the patient
- \- GFR \<15 mL/min/1.73 m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Thomas Kanderlead
Study Sites (1)
Intensive and Perioperative Care. Skåne University Hospital. Lund
Lund, Skåne County, 22185, Sweden
Related Publications (3)
Forauer AR, Theoharis C. Histologic changes in the human vein wall adjacent to indwelling central venous catheters. J Vasc Interv Radiol. 2003 Sep;14(9 Pt 1):1163-8. doi: 10.1097/01.rvi.0000086531.86489.4c.
PMID: 14514808BACKGROUNDWichmann D, Heinemann A, Zahler S, Vogel H, Hopker W, Puschel K, Kluge S. Prospective study of device-related complications in intensive care unit detected by virtual autopsy. Br J Anaesth. 2018 Jun;120(6):1229-1236. doi: 10.1016/j.bja.2018.02.031. Epub 2018 Apr 4.
PMID: 29793590BACKGROUNDRockholt MM, Naddi L, Badri AM, Englund E, Kander T. Macro- and microscopic changes in veins with short-term central venous catheters: an observational autopsy study. BMC Anesthesiol. 2024 Jan 2;24(1):5. doi: 10.1186/s12871-023-02380-x.
PMID: 38166620BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Kander
Lund University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Sponsor investigator
Study Record Dates
First Submitted
May 11, 2024
First Posted
May 16, 2024
Study Start
January 16, 2025
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2028
Last Updated
April 28, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- After the publication of the study up to 3 years after the publication of the study
- Access Criteria
- Researchers may submit requests through the specified channel, detailing the purpose and proposed analyses. Approved applicants will sign a data access agreement, ensuring responsible and transparent use of the data.
Upon reasonable request, de-identified individual participant data from this clinical trial will be shared to facilitate scientific collaboration.